총 97건 중 97건 출력
, 3/10 페이지
-
21
-
Estimación del riesgo cardiovascular y detección de ateromatosis carotídea subclínica en mujeres posmenopáusicas de mediana edad
-
Masson Walter;
Huerín Melina;
Vitagliano Laura;
Zeballos Cecilia;
Lobo Martín;
Rostan María;
Cafferata Alberto;
Manente Diego;
;
(Revista Argentina de Cardiología,
v.81,
2013,
pp.322-328)
-
22
-
Estratificación del riesgo cardiovascular en pacientes con sobrepeso u obesidad en prevención primaria. Implicaciones en la utilización de estatinas
-
Masson, Walter;
Lobo, Martí
n;
Huerí
n, Melina;
Molinero, Graciela;
Manente, Diego;
Pá
ngaro, Mario;
Vitagliano, Laura;
Zylbersztejn, Horacio;
;
(Endocrinología y nutrición : órgano de la sociedad española de endocrinología y nutrición,
v.62,
2015,
pp.83-90)
-
23
-
Vitamin D deficiency is an independent risk factor for PTDM after kidney transplantation
-
Le Fur, Awena;
Fournier, Marie‐
Cé
cile;
Gillaizeau, Florence;
Masson, Damien;
Giral, Magali;
Cariou, Bertrand;
Cantarovich, Diego;
Dantal, Jacques;
Institute of Transplantation, Urology and Nephrology (ITUN), Nantes University Hospital, Nantes, France;
INSERM UMR 1064, Nantes University Hospital, Nantes, France;
Institute of Transplantation, Urology and Nephrology (ITUN), Nantes University Hospital, Nantes, France;
Biochemistry Laboratory, Nantes, France;
Institute of Transplantation, Urology and Nephrology (ITUN), Nantes University Hospital, Nantes, France;
Endocrinology Clinic, Nantes University Hospital, Nantes, France;
Institute of Transplantation, Urology and Nephrology (ITUN), Nantes University Hospital, Nantes, France;
Institute of Transplantation, Urology and Nephrology (ITUN), Nantes University Hospital, Nantes, France;
(Transplant international : official journal of the European Society for Organ Transplantation,
v.29,
2016,
pp.207-215)
-
24
-
Determinação do comportamento de tensões aplicadas a cabos suspensos
-
de Souza Chaves Diego Henrique;
Dias Duarte Iara Campolina;
Masson Miguel Bruno César;
da Costa Junior Esly Ferreira;
;
(Revista Liberato,
v.19,
2018,
pp.215-224)
-
25
-
Abstract 914: Combination analysis of tumor-associated collagen frameworks and tumor immune phenotype of lung carcinomas using virtual staining
-
Alexanian, Serge;
Rivenson, Yair;
Xuan, Ning;
Cone, Brian;
Fang, Zihang;
Meyering, Sean;
Carvalho, Luis A.;
Palacios, David;
Kozikowski, Raymond;
1Pictor Labs, Inc., Los Angeles, CA.;
1Pictor Labs, Inc., Los Angeles, CA.;
1Pictor Labs, Inc., Los Angeles, CA.;
1Pictor Labs, Inc., Los Angeles, CA.;
1Pictor Labs, Inc., Los Angeles, CA.;
1Pictor Labs, Inc., Los Angeles, CA.;
1Pictor Labs, Inc., Los Angeles, CA.;
1Pictor Labs, Inc., Los Angeles, CA.;
1Pictor Labs, Inc., Los Angeles, CA.;
(Cancer research : the official organ of the American Association for Cancer Research, Inc,
v.84,
2024,
pp.914-914)
-
26
-
Infection prevention and control challenges in Flemish homecare nursing: a pilot study
-
Maelegheer, Karel;
Dumitrescu, Irina;
Verpaelst, Nele;
Masson, Hanna;
Broucke, Caroline;
Braekeveld, Pedro;
Backaert, Diego;
Mensaert, Caro;
Leroux-Roels, Isabel;
Floré
, Katelijne;
Microbiologist and Infection Control Specialist, Laboratory Medicine, Medical Microbiology, AZ Sint Lucas, Bruges;
Researcher, Department of Nursing Science and Midwifery, Centre For Research and Innovation in Care, Nurse and Pharmaceutical Care, Faculty of Medicine and Health Sciences, University of Antwerp;
Nursing Expert (Infection Control), Wit-Gele Kruis van Vlaanderen;
Nursing Expert (Infection Control), Wit-Gele Kruis West-Vlaanderen;
Infection Control Experts, Agentschap Zorg en Gezondheid, Flemish Government;
Infection Control Experts, Agentschap Zorg en Gezondheid, Flemish Government;
Homecare nurses, Flemish Infection Control Group of Home Nurses, Flandres;
Homecare nurses, Flemish Infection Control Group of Home Nurses, Flandres;
Homecare nurses, Flemish Infection Control Group of Home Nurses, Flandres;
Microbiologist and Infection Control Specialist, Infection Control Team, Ghent University Hospital;
Microbiologist and Infection Control Specialist, Laboratory Medi;
(British journal of community nursing,
v.25,
2020,
pp.114-121)
-
27
-
Tabaquismo en médicos de la República Argentina II. Estudio TAMARA II
-
Zylbersztejn Horacio;
Masson Walter;
Lobo Lorenzo;
Manente Diego;
García Aurelio Mauro;
Angel Adriana;
Mulassi Andrés;
Giorgi Mariano;
Rostán María;
;
(Revista Argentina de Cardiología,
v.83,
2015,
pp.222-231)
-
28
-
Abstract 3024: HIF1A and HIF2A differentially contribute to early and adaptive changes following <i>in vivo Vhl</i> inactivation in the kidney
-
Kurlekar, Samvid;
Lima, Joanna;
Barros, Ayslan B.;
Masson, Norma;
Zhai, Sophia;
Pugh, Christopher W.;
Adam, Julie;
Ratcliffe, Peter J.;
1University of Oxford, Oxford, United Kingdom.;
1University of Oxford, Oxford, United Kingdom.;
1University of Oxford, Oxford, United Kingdom.;
1University of Oxford, Oxford, United Kingdom.;
1University of Oxford, Oxford, United Kingdom.;
1University of Oxford, Oxford, United Kingdom.;
1University of Oxford, Oxford, United Kingdom.;
1University of Oxford, Oxford, United Kingdom.;
(Cancer research : the official organ of the American Association for Cancer Research, Inc,
v.84,
2024,
pp.3024-3024)
-
29
-
Abstract 1977: ACR-2316: A potentially first-in-class, potent, selective WEE1/PKMYT1 inhibitor rationally designed for superior single agent activity through synergistic disruption of cell cycle checkpoints
-
Wigerup, Caroline;
Nilsson, Helé
n;
Shi, Lei;
Jung, Joon;
Baddour-Sousounis, Joelle;
Cornelius, Ruban;
Lipjankic, Nina;
Muralitharan, Uthira;
Siino, Valentina;
Diez, Ignacio Arribas;
Best, Zachary;
Pasetto, Martina;
Dahlberg, William;
Rafiei, Shahrzad;
Lombardo, Portia;
Jakobsson, Magnus E.;
Improgo, Reina;
Scherer, Christina;
van Duzer, John;
Proia, David A.;
Masson, Kristina;
Blume-Jensen, Peter;
1Acrivon Therapeutics, Lund, Sweden;
;
1Acrivon Therapeutics, Lund, Sweden;
;
2Acrivon Therapeutics, Watertown, MA.;
2Acrivon Therapeutics, Watertown, MA.;
2Acrivon Therapeutics, Watertown, MA.;
1Acrivon Therapeutics, Lund, Sweden;
;
1Acrivon Therapeutics, Lund, Sweden;
;
1Acrivon Therapeutics, Lund, Sweden;
;
1Acrivon Therapeutics, Lund, Sweden;
;
1Acrivon Therapeutics, Lund, Sweden;
;
2Acrivon Therapeutics, Watertown, MA.;
1Acrivon Therapeutics, Lund, Sweden;
;
2Acrivon Therapeutics, Watertown, MA.;
2Acrivon Therapeutics, Watertown, MA.;
2Acrivon Therapeutics, Watertown, MA.;
1Acrivon Therapeutics, Lund, Sweden;
;
2Acrivon Therapeutics, Watertown, MA.;
2Acrivon Therapeutics, Watertown, MA.;
2Acrivon Therapeutics, Watertown, MA.;
2Acrivon Therapeutics, Watertown, MA.;
2Acrivon Therapeutics, Watertown, MA.;
2Acrivon Therapeutics, Watertown, MA.;
(Cancer research : the official organ of the American Association for Cancer Research, Inc,
v.84,
2024,
pp.1977-1977)
-
30
-
Abstract 6622: Identification of early oncogenic lesions following concomitant Vhl and Pbrm1 loss in the murine kidney
-
Lima, Joanna;
Kurlekar, Samvid;
Masson, Norma;
Barros, Ayslan B.;
Soares, Maria Fernanda;
Pugh, Christopher W.;
Adam, Julie;
Ratcliffe, Peter J.;
1University of Oxford, Oxford, United Kingdom.;
1University of Oxford, Oxford, United Kingdom.;
1University of Oxford, Oxford, United Kingdom.;
1University of Oxford, Oxford, United Kingdom.;
1University of Oxford, Oxford, United Kingdom.;
1University of Oxford, Oxford, United Kingdom.;
1University of Oxford, Oxford, United Kingdom.;
1University of Oxford, Oxford, United Kingdom.;
(Cancer research : the official organ of the American Association for Cancer Research, Inc,
v.84,
2024,
pp.6622-6622)